Cargando...

Functional observation after morphine withdrawal: effects of SJP-005

RATIONALE AND OBJECTIVE: SJP-005 (ketotifen and ibuprofen) is being developed as a potential new treatment for opioid withdrawal. Three studies were conducted to evaluate the early phase (acute, day 1) and late phase (days 2–12) effects of SJP-005 on discontinuation-induced morphine withdrawal. METH...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Psychopharmacology (Berl)
Autores principales: Verster, Joris C., Scholey, Andrew, Dahl, Thomas A., Iversen, Jacqueline M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8139893/
https://ncbi.nlm.nih.gov/pubmed/33555386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00213-021-05771-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!